文献速递瓣膜外科

经导管主动脉瓣植入术中紧急中转外科手术的发生率与结局:来自大型三级医疗中心的见解

Incidence and outcomes of emergency intraprocedural surgical conversion during transcatheter aortic valve implantation: Insights from a large tertiary care centre.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

该研究分析2006至2020年莱比锡心脏中心6903例经股动脉TAVI患者,74例(1.1%)需紧急中转开胸手术。中转率从P1的3.5%降至P3的0.4%(P<0.001)。高危患者院内死亡62.1%、1年生存31.8%,低/中危患者分别为12.5%和87.5%。

要点

  • TAVI紧急中转开胸手术率为1.1%(74/6903),P1至P3由3.5%降至0.4%(P<0.001)。
  • 中转患者中高危占89.2%,低/中危占10.8%,低/中危比例随时间增加(P=0.077)。
  • 高危患者院内死亡62.1%、1年生存31.8%;低/中危分别为12.5%和87.5%(log-rank P=0.002)。

核心结论

  • 低/中危患者TAVI紧急中转开胸术后院内及1年生存率高于高危患者。
  • 具备立即紧急开胸能力的心外科团队是TAVI团队的重要组成部分。

研究设计与样本

  • 回顾性分析2006至2020年莱比锡心脏中心所有经股动脉TAVI患者数据。
  • 共纳入6903例患者,按手术风险分组:高危为EuroSCORE II ≥6%,低/中危为EuroSCORE II <6%。
  • 研究时间分为3期:2006-2010年(P1)、2011-2015年(P2)、2016-2020年(P3)。

主要发现

  • 74例(1.1%)需紧急中转开胸手术,其中高危66例(89.2%)、低/中危8例(10.8%)。
  • 紧急中转率P1为3.5%(20/577)、P2为1.8%(35/1967)、P3为0.4%(19/4359),P<0.001。
  • 中转患者中低/中危比例P1为0%、P2为8.6%、P3为26.3%(P=0.077)。
  • 术中死亡10例(13.5%),均为高危患者。
  • 院内死亡率高危62.1% vs 低/中危12.5%(P=0.007);1年生存率全部中转患者37.8%、高危31.8% vs 低/中危87.5%(log-rank P=0.002)。

临床怎么用

  • 作者认为,具备立即紧急开胸能力的心外科团队是TAVI团队的重要组成部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: During a transcatheter aortic valve implant (TAVI) procedure, intraprocedural complications that are manageable only by conversion to emergency open-heart surgery (E-OHS) occasionally occur. Contemporary data on the incidence and outcome of TAVI patients undergoing E-OHS are scarce. This study aimed to evaluate early and midterm outcomes following E-OHS of patients undergoing TAVI in a large tertiary care centre with immediate surgical backup availability for all TAVI procedures over a 15-year period. METHODS: Data from all patients undergoing transfemoral TAVI between 2006 and 2020 at the Heart Centre Leipzig were analysed. The study time was divided into 3 periods: 2006-2010 (P1), 2011-2015 (P2) and 2016-2020 (P3). Patients were grouped according to their surgical risk (high risk: EuroSCORE II ≥ 6%; low/intermediate risk: EuroSCORE II <6%). Primary outcomes were intraprocedural and in-hospital death and 1-year survival. RESULTS: During the study period, a total of 6903 patients underwent transfemoral TAVI. Among them, 74 (1.1%) required E-OHS [high risk, n = 66 (89.2%); low/intermediate risk, n = 8 (10.8%)]. The rate of patients requiring E-OHS was 3.5% (20/577 patients), 1.8% (35/1967 patients) and 0.4% (19/4359 patients) in study periods P1 to P3, respectively (P < 0.001). The proportion of patients who had E-OHS who were low/intermediate risk increased considerably over time (P1:0%; P28.6%; P3:26.3%; P = 0.077). Intraprocedural deaths occurred in 10 patients (13.5%), all of whom were high-risk. In-hospital mortality was 62.1% in high-risk patients and 12.5% in low/intermediate risk patients (P = 0.007). One-year survival was 37.8% in all patients undergoing E-OHS, 31.8% in high-risk patients and 87.5% in low/intermediate risk patients (log-rank P = 0.002). CONCLUSIONS: In-hospital and 1-year survival rates following E-OHS are higher in low/intermediate risk than in high-risk patients undergoing TAVI. An on-site cardiac surgical department with immediately available E-OHS capabilities is an important component of the TAVI team.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Marin-Cuartas M, de Waha S, Naumann S, et al. Incidence and outcomes of emergency intraprocedural surgical conversion during transcatheter aortic valve implantation: Insights from a large tertiary care centre. Eur J Cardiothorac Surg. 2023. PMID: 37027228. doi:10.1093/ejcts/ezad142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。